The Nifty small-cap 250 was up 1.87 per cent, while the mid-cap gauge was up 1.35 per cent
Share Market Highlights: Broader indices mirrored the benchmarks, with smallcap shares leading the charge as the Nifty Smallcap100 index ended higher by 2.71 per cent
However, thus far in the calendar year 2025, the BSE Smallcap index has underperformed the market by falling 20%, as against 14% decline in BSE Midcap index and 4% drop in BSE Sensex.
The stock price of NACL has surged 16% to Rs 107.40 in intra-day trade on Monday and zoomed 99% thus far in the month of March.
Known as the Dow Theory, it holds that moves in the Dow Jones Industrial Average must be confirmed by transport stocks, and vice versa, to be sustained
However, in past six months, DMart has underperformed the market by falling 25 per cent, as against 11 per cent decline in the BSE Sensex.
The hotel industry is poised to continue its strong recovery in Q4FY25, fueled by healthy traction in MICE activities, cultural events, and a strong wedding season, believe analysts at Motilal Oswal.
Sarda Energy & Minerals share price moved higher by 9 per cent to Rs 514.65 on the BSE in Monday's intra-day trade amid heavy volumes in an otherwise weak broader market.
Shares of Camlin Fine Sciences (CFSL) hit a 17-month high at Rs 169.70, as they rallied 5 per cent on the BSE in Thursday's intra-day trade on heavy volumes.
Market analysts attribute this rally to the recent correction in the mid- and small-cap stocks, citing that it created attractive opportunities for long-term investors
The auto-component maker has an ambitious vision to be among the Top Five Shock Absorber Manufacturers in the World and is relentlessly working towards it.
According to Ambreesh Baliga, an independent analyst, "It's essentially a pullback rally following a prolonged decline in the Indian market."
Jindal Worldwide today turned ex-date for 4:1 bonus issue; i.e. 4 new equity shares for every 1 existing equity share to the eligible equity shareholders of the company as on the record date.
INOX India said it achieved a historic milestone by becoming India's first cryogenic equipment manufacturer to receive the prestigious IATF 16949 certification for cryogenic fuel tank manufacturing.
Keeping the price-earnings (PE) multiple intact, our (Nifty) index target gets revised to 27,000 levels i.e. nearly 21x PE on FY27 EPS of Rs 1,300
Suven Pharma is set to benefit from high-growth cutting-edge CDMO segments and its proven track record to drive traditional business.
The management said sales in international markets are showing strong growth, and expect this momentum to accelerate with the launch of new products.
Technically, a RSI reading above 70 is considered overbought for the stock, which could mean the stock may consolidate or correct in the near-term; but not necessarily fall.
Citigroup Inc. and HSBC Holdings Plc are among banks that have cut profit forecasts as the latest earnings from some of India's top firms
DIIs, retail and proprietary traders continue to hold bullish bets in index futures, shows NSE derivative data. Technically, Nifty near support rises to 23,630.